20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. IBM
3. PRIM
4. MU
5. ACN
6. NAVN
7. DFTX
8. META
9. IMNN
10. DPZ

Go back to 20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program
(NASDAQ: AIDX) Delayed: 0.61 --0 (-0%)
Previous Close $0.61    52 Week High $ 
Open $0.61    52 Week Low $ 
Day High $0.61    P/E N/A 
Day Low $0.61    EPS $ 
Volume 25,861       

(NASDAQ: AIDX) Delayed: 0.61 --0 (-0%)
Previous Close $0.61    52 Week High $ 
Open $0.61    52 Week Low $ 
Day High $0.61    P/E N/A 
Day Low $0.61    EPS $ 
Volume 25,861